[The effect of surgical revascularization on different timing after ST-elevation myocardial infarction on patients

Rong Wang1, Changqing Gao1, Cangsong Xiao1

  • 1Department of Cardiovascular Surgery, Peoples' Liberation Army General Hospital, Institute of Cardiac Surgery of People's Liberation Army, Beijing 100853, China.

Insights

Surgical revascularization after ST-elevation myocardial infarction (STEMI) improves left ventricular function and remodeling. Optimal timing for coronary artery bypass grafting is recommended around three weeks post-STEMI for patients with left ventricular dysfunction.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Cardiovascular Research

Background:

  • ST-elevation myocardial infarction (STEMI) frequently leads to left ventricular dysfunction.
  • Coronary artery disease (CAD) with impaired left ventricular function requires effective treatment strategies.
  • Surgical revascularization is a key intervention for managing advanced CAD.

Purpose of the Study:

  • To analyze the influence of different surgical revascularization timings post-STEMI on patients with CAD and left ventricular dysfunction.
  • To evaluate the impact of early, mid-term, and late revascularization on patient outcomes.
  • To determine the optimal timing for coronary artery bypass grafting (CABG) after STEMI.

Main Methods:

  • Retrospective review of 225 patients with STEMI and ejection fraction <50% who underwent isolated CABG.
  • Patients were divided into early (<21 days), mid-term (21-90 days), and late (>90 days) revascularization groups.
  • Endpoints included 30-day post-operative mortality and major complications, with assessment of cardiac function and remodeling.

Main Results:

  • No significant difference in 30-day mortality across revascularization timing groups.
  • Significantly lower mortality from low cardiac output syndrome in mid-term and late revascularization groups compared to early.
  • Significant improvement in ejection fraction and reduction in left ventricular end-diastolic dimension observed in mid-term and late groups.

Conclusions:

  • Surgical revascularization benefits patients with CAD and left ventricular dysfunction, improving cardiac function and remodeling.
  • Short-term outcomes are influenced by patient condition, surgical technique, and perioperative management.
  • Revascularization approximately three weeks after STEMI is recommended for this patient cohort.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
442
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
499
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562